Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cullinan Therapeutics, Inc.CGEM · Entity 4766 | Director | June 16, 2026 | June 18, 2026 |
| Radius Health, Inc.RDUS · Entity 124173 | Director | February 26, 2020 | February 28, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cullinan Therapeutics, Inc.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $13.55 · Expires 2026-06-16 | Direct | 25,319 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 25,319 · Balance 25,319 F1: The option represents a right to purchase a total of 25,319 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 16, 2027 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: The option represents a right to purchase a total of 25,319 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 16, 2027 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date.
Radius Health, Inc.
Report date February 26, 2020 · Filed February 28, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,401 |
Reported balance
After 2020-02-26 transaction · row 1
1 source rowRow 1 · 2020-02-26 · Sale · Disposed 1,815 · Balance 12,401 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
F2: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 21:00 UTC | Cullinan Therapeutics, Inc. CGEM · Entity 4766 | GrantStock Option (Right to Buy) · Derivative | 25,319 | $0.00 Strike: $13.55 | $0.00 |
DisclosureSEC source: 0001193125-26-276060 · ownership.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,319 Underlying: Common Stock · 25,319 shares Expires 2026-06-16 F1 · derivative.exercise_date: The option represents a right to purchase a total of 25,319 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 16, 2027 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:12 UTC | Cullinan Therapeutics, Inc. CGEM · Entity 4766 | GrantStock Option (Right to Buy) · Derivative | 38,513 | $0.00 Strike: $8.95 | $0.00 |
DisclosureSEC source: 0000950170-25-086732 · ownership.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,513 Underlying: Common Stock · 38,513 shares Expires 2035-06-12 F1 · derivative.exercise_date: The option represents a right to purchase a total of 38,513 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 12, 2026 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date Read SEC document |
| June 26, 2024 Filed Jun 27, 2024 23:00 UTC | Cullinan Therapeutics, Inc. CGEM · Entity 4766 | GrantStock Option (Right to Buy) · Derivative | 15,806 | $0.00 Strike: $16.50 | $0.00 |
DisclosureSEC source: 0000950170-24-078677 · ownership.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,806 Underlying: Common Stock · 15,806 shares Expires 2034-06-26 F1 · derivative.exercise_date: The option represents a right to purchase a total of 15,806 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 26, 2025 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 21:57 UTC | Cullinan Therapeutics, Inc. CGEM · Entity 4766 | GrantStock Option (Right to Buy) · Derivative | 18,450 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0000950170-23-027539 · ownership.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,450 Underlying: Common Stock · 18,450 shares Expires 2033-06-07 F1 · derivative.exercise_date: The option represents a right to purchase a total of 18,450 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 8, 2024 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date. Read SEC document |
| June 22, 2022 Filed Jun 23, 2022 22:16 UTC | Cullinan Therapeutics, Inc. CGEM · Entity 4766 | GrantStock Option (Right to Buy) · Derivative | 16,475 | $0.00 Strike: $12.73 | $0.00 |
DisclosureSEC source: 0000899243-22-023767 · doc4.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,475 Underlying: Common Stock · 16,475 shares Expires 2032-06-21 F1 · derivative.exercise_date: The option represents a right to purchase a total of 16,475 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 22, 2023 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date. Read SEC document |
| September 16, 2021 Filed Mar 25, 2022 23:34 UTC | Cullinan Therapeutics, Inc. CGEM · Entity 4766 | GrantStock Option (Right to Buy) · Derivative | 7,800 | $0.00 Strike: $28.80 | $0.00 |
DisclosureSEC source: 0000899243-22-012378 · doc4.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,800 Underlying: Common Stock · 7,800 shares Expires 2031-09-15 F1 · derivative.exercise_date: The option represents a right to purchase a total of 7,800 shares of the Issuer's Common Stock, which shall vest in full on the earlier of (i) June 25, 2022 or (ii) the date of the Issuer's next annual meeting, subject to the Reporting Person's continued service as a director on such vesting date. Read SEC document |
| February 26, 2020 Filed Feb 28, 2020 21:15 UTC | Radius Health, Inc. RDUS · Entity 124173 | SaleCommon Stock | 1,815 | $17.95 | $32,579.25 |
DisclosureSEC source: 0001209191-20-013792 · doc4.xml · nonDerivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,401 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 23:01 UTC | Radius Health, Inc. RDUS · Entity 124173 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $19.96 | $0.00 |
DisclosureSEC source: 0001209191-20-012156 · doc4.xml · derivative · entry 2 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-02-20 F2 · derivative.exercise_date: The option vests in full on February 20, 2021, subject to continued service with RDUS through such date. Read SEC document |
| February 20, 2020 Filed Feb 24, 2020 23:01 UTC | Radius Health, Inc. RDUS · Entity 124173 | GrantCommon Stock | 5,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-012156 · doc4.xml · nonDerivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,216 F1 · price: The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on February 20, 2021, subject to continued service with RDUS through such date. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 20:02 UTC | Radius Health, Inc. RDUS · Entity 124173 | SaleCommon Stock | 1,584 | $24.60 | $38,966.40 |
DisclosureSEC source: 0001209191-19-041027 · doc4.xml · nonDerivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,716 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · shares: Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 23:17 UTC | Radius Health, Inc. RDUS · Entity 124173 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $19.18 | $0.00 |
DisclosureSEC source: 0001209191-19-013720 · doc4.xml · derivative · entry 2 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-02-22 F2 · derivative.exercise_date: The option vests in full on February 22, 2020, subject to continued service with RDUS through such date. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 23:17 UTC | Radius Health, Inc. RDUS · Entity 124173 | GrantCommon Stock | 5,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-013720 · doc4.xml · nonDerivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,300 F1 · price: The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on February 22, 2020, subject to continued service with RDUS through such date. Read SEC document |
| February 13, 2019 Filed Feb 13, 2019 22:24 UTC | Radius Health, Inc. RDUS · Entity 124173 | Exercise / conversionRestricted Stock Units · Derivative | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009760 · doc4.xml · derivative · entry 2 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,800 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. F2 · derivative.exercise_date: The restricted stock units vested in full on February 13, 2019. F2 · derivative.expiration_date: The restricted stock units vested in full on February 13, 2019. Read SEC document |
| February 13, 2019 Filed Feb 13, 2019 22:24 UTC | Radius Health, Inc. RDUS · Entity 124173 | Exercise / conversionCommon Stock | 4,800 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-009760 · doc4.xml · nonDerivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 00:48 UTC | Radius Health, Inc. RDUS · Entity 124173 | GrantRestricted Stock Units · Derivative | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-010555 · doc4.xml · derivative · entry 2 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,800 Underlying: Common Stock · 4,800 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. F3 · derivative.exercise_date: The restricted stock units shall vest in full on February 13, 2019. F3 · derivative.expiration_date: The restricted stock units shall vest in full on February 13, 2019. Read SEC document |
| February 13, 2018 Filed Feb 16, 2018 00:48 UTC | Radius Health, Inc. RDUS · Entity 124173 | GrantStock Option (Right to Buy) · Derivative | 8,800 | $0.00 Strike: $37.83 | $0.00 |
DisclosureSEC source: 0001209191-18-010555 · doc4.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,800 Underlying: Common Stock · 8,800 shares Expires 2028-02-12 F1 · derivative.exercise_date: The option vests in full on February 13, 2019, subject to continued service to the Issuer through such date. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 21:29 UTC | Radius Health, Inc. RDUS · Entity 124173 | GrantStock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $45.65 | $0.00 |
DisclosureSEC source: 0001209191-17-013266 · doc4.xml · derivative · entry 1 Rosenberg Anthony · CIK 0001466175 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2027-02-16 F1 · derivative.exercise_date: The option vests in full on February 17, 2018, subject to continued service to the Issuer through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.